CD24 Protein-VLP, Cynomolgus, Recombinant

CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers.

Pack Size	Availability	Price/USD
100 μg	5 days	$ 1,850.00
500 μg	5 days	$ 7,460.00
1 mg	5 days	$ 12,430.00

Pack Size

Availability

Price/USD

Quantity

100 μg

5 days

$ 1,850.00

500 μg

5 days

$ 7,460.00

1 mg

5 days

$ 12,430.00

Description

Species	Cynomolgus
Expression System	HEK293
Accession Number	XP_015304503.1
Synonyms	MGC75043, CD 24, FLJ43543, FLJ22950, CD24 molecule, CD24A
Construction	Recombinant Cynomolgus CD24 Protein-VLP is expressed from HEK293. It contains Ser26-Gly57.[Accession \|XP_015304503.1]
Protein Purity	> 90% as determined by HPLC
Molecular Weight	The target protein has a predicted MW of 3.8 kDa.

Endotoxin	Less than 1EU per μg by the LAL method.
Formulation	Supplied as 0.22μm filtered solution in PBS (pH 7.4).Notice: If you need it for immunization, Do Not use any adjuvant.
Stability & Storage	Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Shipping	In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Research Background	CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers.